The Enterprise Value as of December 2025 (TTM) for Oryzon Genomics S.A. (ORYZF) is 234.95M

According to Oryzon Genomics S.A.’s latest financial reports and current stock price. The company's current Enterprise Value is 234.95M. This represents a change of 159.72% compared to the average of 90.46M of the last 4 quarters.

Oryzon Genomics S.A. (ORYZF) Historical Enterprise Value (quarterly & annually)

How has ORYZF Enterprise Value performed in the past?

The mean historical Enterprise Value of Oryzon Genomics S.A. over the last ten years is 79.61M. The current 234.95M Enterprise Value has changed 29.41% with respect to the historical average. Over the past ten years (40 quarters), ORYZF's Enterprise Value was at its highest in in the December 2022 quarter at 174.05M. The Enterprise Value was at its lowest in in the September 2015 quarter at 0.

Oryzon Genomics S.A. (ORYZF) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Oryzon Genomics S.A. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Oryzon Genomics S.A. (ORYZF) Average Enterprise Value

How has ORYZF Enterprise Value performed in the past?

The current Enterprise Value of Oryzon Genomics S.A. (ORYZF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Oryzon Genomics S.A. (ORYZF) Enterprise Value vs. Peers

How is ORYZF’s Enterprise Value compared to its peers?

Oryzon Genomics S.A.’s Enterprise Value is greater than hVIVO plc (3.08M), less than Silence Therapeutics plc (243.70M), greater than Santhera Pharmaceuticals Holding AG (215.74M), less than Genfit S.A. (262.96M), greater than Transgene S.A. (135.53M), less than Hansa Biopharma AB (publ) (3.50B), less than JW (Cayman) Therapeutics Co. Ltd (886.64M), less than NervGen Pharma Corp. (446.62M), less than China Evergrande New Energy Vehicle Group Limited (28.36B), less than Orpea S.A. (9.85B),

Build a custom stock screener for Oryzon Genomics S.A. (ORYZF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Oryzon Genomics S.A. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Oryzon Genomics S.A. (ORYZF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Oryzon Genomics S.A. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.